# GATE 1 VERDICT: FAIL
**Strategy:** H14 OU Mean Reversion Cloud v1.0
**Date:** 2026-03-16
**Source backtest:** QUA-162 / `backtests/H14_OUMeanReversion_2026-03-16.json`

---

## QUANTITATIVE SUMMARY

| Criterion | Threshold | Actual | Result |
|---|---|---|---|
| IS Sharpe | > 1.0 | 0.9033 | ❌ FAIL |
| OOS Sharpe | > 0.70 | -0.0091 | ❌ FAIL |
| Walk-forward consistency | OOS within 30% of IS | N/A (IS negative in W2) | — |
| IS Max Drawdown | < 20% | -1.6% | ✅ PASS |
| OOS Max Drawdown | < 25% | -0.6% | ✅ PASS |
| Win Rate | > 50% | 56.9% | ✅ PASS |
| Deflated Sharpe Ratio | > 0 | 0.000073 | ✅ PASS (marginal) |
| Parameter sensitivity | < 30% Sharpe change | 72% deviation | ❌ FAIL |
| Walk-forward windows passed | ≥ 3/4 | 3/4 | ✅ PASS |
| Post-cost performance | PASS | Included in above | ✅ PASS |
| IS Trade Count (min 50) | ≥ 50 | 160 | ✅ PASS |
| Permutation test | p ≤ 0.05 | p = 0.544 | ❌ FAIL |

**Summary: 4 criteria failing. No automatic disqualification flags (each individual criterion met minimum); however, combined failures across IS Sharpe, OOS Sharpe, parameter sensitivity, and permutation test constitute a clear Gate 1 FAIL.**

---

## KELLY CRITERION ANALYSIS

> **Note:** Kelly analysis is academic here — strategy has failed Gate 1 and is not eligible for promotion. Included for completeness per protocol.

- IS annualized return (4-year period): ~0.56%
- IS annualized vol (derived from Sharpe): ~0.62%
- Kelly fraction (f* = mu/sigma²): **~145** (abnormally high due to ultra-low vol with minimal absolute return)
- **Interpretation:** The anomalously high Kelly fraction reflects a pathological regime — very low absolute return with extremely low annualized vol. This is an artifact of the strategy's market-time exposure (in-market only ~47% of days). Kelly cap is **not binding** since strategy is REJECTED.
- **Flag:** Not applicable (FAIL).

---

## QUALITATIVE ASSESSMENT

**Economic rationale:** VALID — OU mean reversion has solid academic grounding. The κ significance filter (p < 0.05) was enforced. The failure is not conceptual; it is empirical.

**Look-ahead bias:** NONE DETECTED — Risk Director mandated 1+ bar lag on OU re-estimation was enforced per Engineering confirmation.

**Overfitting risk:** HIGH — Parameter sensitivity of 72% (OU lookback: 30→90 bars) shows the strategy's edge is fragile and parameter-contingent. Permutation test (p = 0.544) confirms no statistically significant alpha at 5% level.

**Primary failure modes:**
1. **2022 rate-shock regime break:** OOS Sharpe -0.009 driven by H2 2022. OU equilibrium assumptions break down under structural rate regime shifts — this is a known failure mode for mean-reversion strategies.
2. **No statistically significant alpha (p = 0.544):** 160 IS trades provide sufficient statistical power. The permutation test failure is not a sample-size issue; it reflects genuine signal weakness.
3. **High parameter sensitivity (72%):** The "best" lookback (lb=45, p<0.05: Sharpe=0.94) vs "worst" (lb=30: Sharpe=0.25) spans a 3.7× range. This is a classic overfitting signal.

---

## DISPOSITION

**RECOMMENDATION: Retire — do not revise.**

**Rationale:** Three independent failure signals converge:
- No statistically significant alpha (permutation test p = 0.544)
- 72% parameter sensitivity — the signal is not robust
- OOS collapse in 2022 rate shock — structural regime vulnerability

The OOU model is the correct tool for this type of signal, but the ETF universe (SPY, QQQ, IWM, XLE, XLF, XLK) does not exhibit sufficient mean-reversion persistence at the 30–90 bar horizon to generate reliable signals. The pre-COVID and COVID-era results (IS windows 2018–2021 Sharpe 1.47–2.50) reflect favorable mean-reversion regimes, not a generalizable edge.

**Revision path not recommended:** A parameter search to achieve IS Sharpe > 1.0 would be data-mining on a strategy already shown to have no statistically significant alpha. Risk Director does not recommend further iteration on H14.

**CONFIDENCE: HIGH**

---

*Risk Director — 2026-03-16*
*QUA-162 backtest reference | `backtests/H14_OUMeanReversion_2026-03-16.json`*
